(Press-News.org) SANTA CLARA, Calif. – Embargoed for 2 p.m. EST, November 17, 2010 – Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine ("Femtosecond Laser-Assisted Cataract Surgery with Integrated Optical Coherence Tomography," Volume 2, Issue 58, November 17, 2010). The data showed that, when compared to manual techniques, the Catalys Precision Laser System helped surgeons achieve significant improvement in precision during several critical steps of cataract surgery.
"These study results clearly indicate that a femtosecond laser with integrated Ocular Coherence Tomography (OCT) imaging, advanced optics and control software can provide multiple benefits for cataract surgery," said the study's lead author Daniel Palanker, associate professor, Department of Ophthalmology and Hansen Experimental Physics Laboratory, Stanford University. "We believe the new laser-assisted technique represents a significant scientific and clinical advancement that will make cataract surgery much more precise and reproducible, and we are gratified that Science Translational Medicine has recognized its importance and potential."
As reported in the published study, approximately one third of Americans will undergo cataract surgery in their lifetime. While advancements in surgical technique have occurred over the last several decades, several critical steps remain manual in nature and can only be performed with limited precision. OptiMedica developed the Catalys Precision Laser System to dramatically improve the cataract procedure by replacing its inconsistent, manual steps.
Catalys is designed to perform four incisions: capsulotomy (a circular incision in the lens capsule), lens fragmentation (segmenting and softening of the lens to prepare for removal), relaxing incisions (cuts to correct astigmatism), and cataract incisions (cuts to allow insertion of the surgical tools). Results of the clinical study, which compared 29 laser-treated eyes with 30 manually treated eyes, showed great improvement across these steps. Authors reported:
A 12-fold improvement in precision of sizing the capsulotomy with Catalys, as compared to the manual technique, and a five-fold improvement in the precision of the capsulotomy shape. These findings are significant, as capsulotomy shape and size are known to have a critical impact on refractive outcomes.
A more than two-fold improvement in capsulotomy strength. This has the potential to make the procedure safer by reducing the potential for lens capsule rupture.
A 40 percent reduction in the use of ultrasound energy (Cumulative Dispersed Energy) during phacoemulsification, which has the potential to simplify the process of emulsifying and removing the lens.
"The significant gains in precision we were able to achieve in the clinical study of Catalys represent an incredibly exciting development in the field of cataract surgery," said the publication's co-author William Culbertson, M.D., Professor of Ophthalmology, The Lou Higgins Distinguished Chair in Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami. "A more precise procedure will enable cataract surgeons to more accurately position the IOL, and this is key to visual outcomes."
Dr. Culbertson is chair of OptiMedica's Medical Advisory Board, a group of esteemed cataract experts from around the world who have worked closely with the company during every step of the Catalys Precision Laser System's development. Also on the list of study co-authors are OptiMedica Board of Directors member Mark Blumenkranz, M.D., professor and chairman of the Department of Ophthalmology at Stanford University, and OptiMedica Medical Advisory Board members Neil J. Friedman, M.D., partner, Mid-Peninsula Ophthalmology Medical Group and adjunct clinical associate professor, Stanford University School of Medicine; Barry S. Seibel, M.D., clinical assistant professor of Ophthalmology, Jules Stein Eye Institute, David Geffen School of Medicine, UCLA; Juan F. Batlle, M.D., Centro Laser, Santo Domingo, Dominican Republic; and Jonathan H. Talamo, M.D., associate clinical professor of ophthalmology, Harvard Medical School, Talamo Laser Eye Consultants.
"We are enormously proud of the precision demonstrated in the clinical study of Catalys, and we are very gratified to have the data published in the prestigious journal Science Translational Medicine," said Mark J. Forchette, president and chief executive officer, OptiMedica. "We are privileged to partner with such an outstanding team of scientists and clinicians who have worked tirelessly with us for the last several years to bring a whole new level of innovation to cataract surgery."
INFORMATION:
The Catalys Precision Laser System is not for sale in the United States. OptiMedica expects to launch Catalys worldwide in 2011.
About OptiMedica
OptiMedica Corp. is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. Now exclusively focused in the cataract therapeutic area, the company previously developed and commercialized the PASCAL® Method of retinal photocoagulation, which was acquired by Topcon Corp. in August 2010. Founded in 2004, OptiMedica is headquartered in Santa Clara, Calif. The company is funded by Kleiner Perkins Caufield & Byers, Alloy Ventures, DAG Ventures, BlackRock Private Equity Partners and Bio*One Capital. For more information, please visit www.optimedica.com.
END
They are often accused of being distracting, but recent research has found that action packed video games like Halo and Call of Duty can enhance visual attention, the ability that allows us to focus on relevant visual information. This growing body of research, reviewed in WIREs Cognitive Science, suggests that action based games could be used to improve military training, educational approaches, and certain visual deficits.
The review, authored by a group led by Dr Daphne Bavelier from the University of Rochester, focused on the impact video games have on visual attention, ...
WHAT:
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined a key mechanism by which Bacillus anthracis bacteria initiate anthrax infection despite being greatly outnumbered by immune system scavenger cells. The finding, made by studying genetically modified mice, adds new detail to the picture of early-stage anthrax infection and supports efforts to develop vaccines and drugs that would block this part of the cycle.
To start an infection, anthrax bacteria release a toxin that binds ...
Frontotemporal lobar degeneration (FTLD) refers to a group of disorders associated with degeneration of the frontal and temporal lobes of the brain. Symptoms include dementia, aphasia, and semantic disorders. Mutation of the gene for PGRN is associated with the most common form of FTLD, which is also characterized by inclusions of TDP-43 protein in the brain. Abnormal accumulation of TDP-43 has also been linked with amyotrophic lateral sclerosis (ALS).
While it is clear that a reduction in PGRN is causative for FTLD-TDP, the underlying mechanism is unknown. "Elucidation ...
STANFORD, Calif. — Imagine trying to cut by hand a perfect circle roughly one-third the size of a penny. Then consider that instead of a sheet of paper, you're working with a scalpel and a thin, elastic, transparent layer of tissue, which both offers resistance and tears easily. And, by the way, you're doing it inside someone's eye, and a slip could result in a serious impairment to vision.
This standard step in cataract surgery — the removal of a disc from the capsule surrounding the eye's lens, a procedure known as capsulorhexis — is one of the few aspects of the operation ...
The most widely adopted measure for assessing the state of the world's oceans and fisheries led to inaccurate conclusions in nearly half the ecosystems where it was applied according to new analysis by an international team led by a University of Washington fisheries scientist.
"Applied to individual ecosystems it's like flipping a coin, half the time you get the right answer and half the time you get the wrong answer," said Trevor Branch, a UW assistant professor of aquatic and fishery sciences.
In 1998, the journal Science published a groundbreaking paper that was ...
LA JOLLA, CA-With few exceptions, jumping genes-restless bits of DNA that can move freely about the genome-are forced to stay put. In patients with Rett syndrome, however, a mutation in the MeCP2 gene mobilizes so-called L1 retrotransposons in brain cells, reshuffling their genomes and possibly contributing to the symptoms of the disease when they find their way into active genes, report researchers at the Salk Institute for Biological Studies.
Their findings, published in the November 18, 2010 issue of the journal Nature, could not only explain how a single mutation ...
STANFORD, Calif. — Researchers at the Stanford University School of Medicine, applying a state-of-the-art imaging system to brain-tissue samples from mice, have been able to quickly and accurately locate and count the myriad connections between nerve cells in unprecedented detail, as well as to capture and catalog those connections' surprising variety.
A typical healthy human brain contains about 200 billion nerve cells, or neurons, linked to one another via hundreds of trillions of tiny contacts called synapses. It is at these synapses that an electrical impulse traveling ...
Physicists working at the European Organization for Nuclear Research (CERN) in Geneva, Switzerland, have succeeded in trapping antihydrogen – the antimatter equivalent of the hydrogen atom – a milestone that could soon lead to experiments on a form of matter that disappeared mysteriously shortly after the birth of the universe 14 billion years ago.
The first artificially produced low energy antihydrogen atoms – consisting of a positron, or antimatter electron, orbiting an antiproton nucleus – were created at CERN in 2002, but until now the atoms have struck normal matter ...
LA JOLLA, CA – November 15, 2010 –– A team led by scientists from The Scripps Research Institute has developed a powerful new method for detecting functional sites on proteins. The technique may have broad applications in basic research and drug development.
Described in an advance, online publication of Nature on November 17, 2010, the method enables scientists to take a sample of cells, locate the sites on their proteins that have a certain kind of biochemical reactivity, and measure the degree of that reactivity.
"It lets us find functional sites on proteins more ...
CHICAGO --- Estrogen is an elixir for the brain, sharpening mental performance in humans and animals and showing promise as a treatment for disorders of the brain such as Alzheimer's disease and schizophrenia. But long-term estrogen therapy, once prescribed routinely for menopausal women, now is quite controversial because of research showing it increases the risk of cancer, heart disease and stroke.
Northwestern Medicine researchers have discovered how to reap the benefits of estrogen without the risk. Using a special compound, they flipped a switch that mimics the effect ...
